Amy DiCamillo

Amy DiCamillo is Director of Behavioral & Pain Pharmacology and is responsible for managing multiple research projects. Amy has 19 years experience in the Pharmaceutical industry, and has acquired considerable expertise in preclinical drug discovery and development, mainly in CNS behavioral models.  

Amy passionately strives for excellence and believes that attention to detail is a critical component for producing quality data. She has worked to develop, validate, and optimize behavior assays for the drug discovery environment under these guiding principles.

Prior to joining Melior Discovery, Amy was a Research Scientist at Cephalon where she worked in CNS biology developing in vivo animal models for cognition, anxiety/depression, locomotor activity, and pain. Amy received her M.S. from the West Chester University of PA where she studied the locomotor effects of Modafinil in MPTP mice while working full-time at Cephalon.  

During her 19 years in drug discovery, Amy has authored or coauthored over 20 peer reviewed articles or scientific meeting presentations. Amy enjoys developing new animal behavior models and troubleshooting the challenges that are often posed in the process. When not working she also enjoys spending time with her family and releasing energy through zumba and step aerobics classes.

Amy DiCamillo is the key contact for discussing in vivo behavioral models.